Opportunity Information: Apply for PAR 18 583
The National Institutes of Health (NIH) grant opportunity titled "Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01, Clinical Trials Not Allowed)" (Funding Opportunity Number PAR-18-583) supports the Gabriella Miller Kids First Pediatric Research Program (Kids First). The main purpose is to generate high-quality genomic data from pediatric cohorts so researchers can better understand the genetic drivers of childhood cancers and the genetic causes of structural birth defects. Rather than funding a traditional hypothesis-driven research project with extensive experimental work, this mechanism is centered on enabling whole genome sequencing (and, when appropriate, other sequencing approaches) on valuable existing patient samples, with the resulting datasets contributed back to a shared national data resource.
At its core, this opportunity invites investigators and institutions to submit samples from pediatric cohorts for sequencing at a Kids First-supported sequencing center. Applicants are encouraged to focus on two major directions: (1) sequencing existing pediatric cancer cohorts to clarify how inherited and tumor-acquired genetic variation contributes to childhood cancers, and (2) expanding the range of disorders represented in the Kids First Data Resource by sequencing cohorts affected by structural birth defects, with the goal of uncovering genetic etiologies that have been difficult to resolve using smaller datasets or less comprehensive technologies. While whole genome sequencing is a central emphasis, the program also makes exome sequencing and transcriptome sequencing available, including sequencing of tumors or other affected tissues when there is a clear scientific justification. This flexibility is meant to ensure that the chosen sequencing strategy matches the biology and the research questions, such as pairing germline and tumor genomes in cancer, or using transcriptome data to interpret functional consequences of variants in affected tissues.
A defining feature of the program is its commitment to broad data sharing and building community resources. Data generated through supported sequencing do not remain solely within the applicant's laboratory; instead, they become part of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource). The intent is to accelerate discovery by making harmonized, well-characterized pediatric genomic datasets available to the wider pediatric research community, enabling cross-cohort analyses, meta-analyses, and replication studies that are often impossible when data are siloed. In practical terms, applicants should expect that participation includes an expectation of contributing data and associated metadata in a way that supports downstream use by other researchers, consistent with applicable consent, privacy, and data governance requirements.
This opportunity uses the X01 funding instrument (a grant mechanism) and is categorized under Health (CFDA number 93.310). Clinical trials are not allowed under this announcement, reinforcing that the program is not designed to test interventions or prospectively assign participants to treatments. Instead, it is focused on genomic sequencing and the creation of research-ready datasets derived from pediatric cohorts.
Eligibility is broad and includes many types of domestic U.S. applicants, such as state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations (both 501(c)(3) and non-501(c)(3), excluding higher education institutions where applicable); for-profit organizations other than small businesses; and small businesses. In addition, the announcement explicitly highlights other eligible applicant categories that reflect a strong inclusion focus, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This breadth is designed to encourage participation from a wide range of institutions that may have access to unique pediatric cohorts, including underserved populations and geographically diverse communities.
Key administrative details provided in the source include an original closing date of 2018-03-22 and a creation date of 2018-01-16. The award ceiling and expected number of awards are not specified in the provided listing. Overall, the opportunity is best understood as a pathway for qualified groups that already have access to pediatric samples and cohorts to obtain high-value whole genome (and related) sequencing through the Kids First infrastructure, while ensuring that the resulting data strengthen a national pediatric genomic resource intended to speed up discoveries in childhood cancer and structural birth defects.Apply for PAR 18 583
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01, Clinical Trials Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
- This funding opportunity was created on 2018-01-16.
- Applicants must submit their applications by 2018-03-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)
Previous opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R21 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 583
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 583) also looked into and applied for these:
| Funding Opportunity |
|---|
| Medications Development for the Treatment of Alcohol Use Disorder - CT optional (U01) Apply for RFA AA 18 009 Funding Number: RFA AA 18 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required) Apply for PAR 18 585 Funding Number: PAR 18 585 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 018 Funding Number: RFA RM 18 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed) Apply for RFA AG 19 001 Funding Number: RFA AG 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 017 Funding Number: RFA RM 18 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed) Apply for RFA RM 18 001 Funding Number: RFA RM 18 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) Apply for PAR 18 595 Funding Number: PAR 18 595 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional) Apply for PAR 18 587 Funding Number: PAR 18 587 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional) Apply for PAR 18 588 Funding Number: PAR 18 588 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 594 Funding Number: PAR 18 594 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 18 597 Funding Number: PAR 18 597 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 596 Funding Number: PAR 18 596 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Coordination Center for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 Clinical Trial Not Allowed) Apply for RFA HL 19 001 Funding Number: RFA HL 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $320,000 |
| Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) Apply for RFA HL 19 002 Funding Number: RFA HL 19 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 608 Funding Number: PAR 18 608 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 607 Funding Number: PA 18 607 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 610 Funding Number: PA 18 610 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) Apply for PA 18 613 Funding Number: PA 18 613 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R44) - Clinical Trial Required Apply for PAR 18 618 Funding Number: PAR 18 618 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R42) - Clinical Trial Required Apply for PAR 18 617 Funding Number: PAR 18 617 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 583", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
